Buy/Sell: Wall Street’s top 10 stock calls this week Editas Medicine downgraded to Underperform from Buy at BofA Editas upgraded at Evercore ISI on value of reni-cel, CRISPR platform Editas Medicine upgraded to Outperform from In Line at Evercore ISI Continue Reading Latest News Feed ...
EDITStockUSD1.210.021.63% Editas Medicine pattern recognition tool provides the execution environment for running the Counterattack recognition and other technical functions against Editas Medicine. Editas Medicine value trend is the prevailing direction of the price over some defined period of time. The ...